Study of the rifampin monoresistance mechanism in mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 2, 2013, Pages 893-900

  Pang, Yu ^a   Lu, Jie ^b   Wang, Yufeng ^a   Song, Yuanyuan ^a   Wang, Shengfen ^a   Zhao, Yanlin ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE ACADEMY OF INSPECTION AND QUARANTINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA SEQUENCE; EXPRESSION VECTOR; GENOTYPE; HYDROGEN BOND; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; MUTANT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYLOGENETIC TREE; POINT MUTATION; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ETHAMBUTOL; GENOTYPE; ISONIAZID; KANAMYCIN; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RIFAMPIN; SEQUENCE ANALYSIS, DNA; STREPTOMYCIN; TUBERCULOSIS;

EID: 84872866033     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01024-12     Document Type: Article

References (36)

1. World Health Organization. 2011. WHO report 2010: Global tuberculosis control. WHO/HTM/TB/2011.16. World Health Organization, Geneva, Switzerland.
2. Faustini A, Hall AJ, Perucci CA. 2005. Tuberculosis treatment outcomes in Europe: A systematic review. Eur. Respir. J. 26:503-510.
3. World Health Organization. 2008. Anti-tuberculosis drug resistance in the world. Report no. 4. WHO/HTM/TB/2008.394. World Health Organization, Geneva, Switzerland.
4. Louw GE, Warren RM, Gey van Pittius NC, McEvoy CR, Van Helden PD, Victor TC. 2009. A balancing act: Efflux/influx in mycobacterial drug resistance. Antimicrob. Agents Chemother. 53:3181-3189.
5. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29.
6. Zhang Y. 2005. The magic bullets and tuberculosis drug targets. Annu. Rev. Pharmacol. Toxicol. 45:529-564.
7. Mitchison DA, Nunn AJ. 1986. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am. Rev. Respir. Dis. 133:423-430.
8. Somoskovi A, Parsons LM, Salfinger M. 2001. The molecular basis of resistance to isoniazid, RIF, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2:164-168.
9. Felmlee TA, Liu Q, Whelen AC, Williams D, Sommer SS, Persing DH. 1995. Genotypic detection of Mycobacterium tuberculosis RIF resistance: Comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J. Clin. Microbiol. 33:1617-1623.
10. Garcia de Viedma D, del Sol Diaz Infantes M, Lasala F, Chaves F, Alcala L, Bouza E. 2002. New real-time PCR able to detect in a single tube multiple RIF resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J. Clin. Microbiol. 40:988-995.
11. McClure WR, Cech CL. 1978. On the mechanism of rifampicin inhibition of RNA synthesis. J. Biol. Chem. 253:8949-8956.
12. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:717-731.
13. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA. 2001. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104:901-912.
14. Gamboa F, Cardona PJ, Manterola JM, Lonca J, Matas L, Padilla E, Manzano JR, Ausina V. 1998. Evaluation of a commercial probe assay for detection of RIF resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur. J. Clin. Microbiol. Infect. Dis. 17:189-192.
15. Kocagoz T, Saribas Z, Alp A. 2005. Rapid determination of RIF resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR. J. Clin. Microbiol. 43:6015-6019.
16. Mariam DH, Mengistu Y, Hoffner SE, Andersson DI. 2004. Effect of rpoB mutations conferring RIF resistance on fitness of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48:1289-1294.
17. Ohno H, Koga H, Kohno S, Tashiro T, Hara K. 1996. Relationship between RIF MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40:1053-1056.
18. Pasca MR, Guglierame P, Arcesi F, Bellinzoni M, De Rossi E, Riccardi G. 2004. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48: 3175-3178.
19. Ainsa JA, Blokpoel MC, Otal I, Young DB, De Smet KA, Martin C. 1998. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J. Bacteriol. 180:5836-5843.
20. Gupta AK, Katoch VM, Chauhan DS, Sharma R, Singh M, Venkatesan K, Sharma VD. 2010. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microb. Drug Resist. 16:21-28.
21. Pang Y, Zhou Y, Wang S, Lu J, Lu B, He G, Wang L, Zhao Y. 2011. A novel method based on high resolution melting (HRM) analysis for MIRU-VNTR genotyping of Mycobacterium tuberculosis. J. Microbiol. Methods 86:291-297.
22. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH. 1998. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36:362-366.
23. Pang Y, Zhou Y, Zhao B, Liu G, Jiang G, Xia H, Song Y, Shang Y, Wang S, Zhao YL. 2012. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One 7:e32976. doi:10.1371/journal.pone.0032976.
24. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D. 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:4498-4510.
25. McNerney R, Kiepiela P, Bishop KS, Nye PM, Stoker NG. 2000. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin. Int. J. Tuberc. Lung Dis. 4:69-75.
26. Mikhailovich V, Lapa S, Gryadunov D, Sobolev A, Strizhkov B, Chernyh N, Skotnikova O, Irtuganova O, Moroz A, Litvinov V, Vladimirskii M, Perelman M, Chernousova L, Erokhin V, Zasedatelev A, Mirzabekov A. 2001. Identification of RIF-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J. Clin. Microbiol. 39:2531-2540.
27. Zhou J, Dong Y, Zhao X, Lee S, Amin A, Ramaswamy S, Domagala J, Musser JM, Drlica K. 2000. Selection of antibiotic-resistant bacterial mutants: Allelic diversity among fluoroquinolone-resistant mutations. J. Infect. Dis. 182:517-525.
28. Baysarowich J, Koteva K, Hughes DW, Ejim L, Griffiths E, Zhang K, Junop M, Wright GD. 2008. Rifamycin antibiotic resistance by ADPribosylation: Structure and diversity of Arr. Proc. Natl. Acad. Sci. U. S. A. 105:4886-4891.
29. da Silva PE, Von Groll A, Martin A, Palomino JC. 2011. Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. FEMS Immunol. Med. Microbiol. 63:1-9.
30. De Rossi E, Arrigo P, Bellinzoni M, Silva PA, Martin C, Ainsa JA, Guglierame P, Riccardi G. 2002. The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. Mol. Med. 8:714-724.
31. Jiang X, Zhang W, Zhang Y, Gao F, Lu C, Zhang X, Wang H. 2008. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb. Drug Resist. 14:7-11.
32. Padiadpu J, Vashisht R, Chandra N. 2010. Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance. Syst. Synth. Biol. 4:311-322.
33. Sharma S, Kumar M, Nargotra A, Koul S, Khan IA. 2010. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 65:1694-1701.
34. Malen H, De Souza GA, Pathak S, Softeland T, Wiker HG. 2011. Comparison of membrane proteins of Mycobacterium tuberculosis H37Rv and H37Ra strains.BMCMicrobiol. 11:18. doi:10.1186/1471-2180-11-18.
35. Ma X, Wang H, Deng Y, Liu Z, Xu Y, Pan X, Musser JM, Graviss EA. 2006. rpoB gene mutations and molecular characterization of RIFresistant Mycobacterium tuberculosis isolates from Shandong Province, China. J. Clin. Microbiol. 44:3409-3412.
36. Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopec E, Zwolska Z, Kirikae F, Toyota E, Kobayashi I, Morita K, Kudo K, Kato S, Kuratsuji T, Mori T, Kirikae T. 2007. Detection of multidrug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45:179-192.